Clinical Trial

TReating Incontinence for Underlying Mental and Physical Health

Study acronym: TRIUMPH
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2022-05-02; most recent amendment 2026-03-04.
Status change: Not Yet Recruiting → Recruiting 2022-09-21
Trial Details
NCT Number NCT05362292
Lead Sponsor University of California, San Francisco
Collaborators: National Institute on Aging (NIA)
Conditions Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder, Incontinence, Urge, Incontinence, Urinary, Incontinence
Enrollment 270 participants
Start Date 2022-10-04
Primary Completion 2027-05-02 (estimated)
Study Completion 2027-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-06